CR2 BINDING PROTEINS AND THEIR USE IN MEDICAL THERAPY
The present invention provides CR2 binding proteins which bind to human CR2, pharmaceutical compositions comprising said CR2 binding proteins and their use in the treatment or prevention of autoimmune and/or inflammatory conditions, infectious diseases and malignancies associated with the Epstein-Ba...
Saved in:
Main Authors | , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
06.07.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides CR2 binding proteins which bind to human CR2, pharmaceutical compositions comprising said CR2 binding proteins and their use in the treatment or prevention of autoimmune and/or inflammatory conditions, infectious diseases and malignancies associated with the Epstein-Barr virus (EBV); and their use as vaccine adjuvants/antigen carriers. |
---|---|
Bibliography: | Application Number: EP20200767985 |